Holen Sie sich die Stockscreener-App
26.35
0.92%
0.24
Xoma Royalty Corp Aktie (XOMA) Neueste Nachrichten
XOMA Royalty Declares Quarterly Preferred Stock Dividends - GlobeNewswire
XOMA Preferred Stock Pays High-Yield Quarterly Dividend: 8.625% Series A, 8.375% Series B - Stock Titan
Bank of America Corp DE Acquires 2,009 Shares of XOMA Co. (NASDAQ:XOMA) - Defense World
XOMA Co. (NASDAQ:XOMA) Shares Sold by Squarepoint Ops LLC - Defense World
Nuveen Asset Management LLC Increases Stock Position in XOMA Co. (NASDAQ:XOMA) - Defense World
XOMA Co. (NASDAQ:XOMA) Shares Sold by BNP Paribas Financial Markets - Defense World
BioInvent secured up to $30 million from XOMA Royalty - Biostock
Wall Street Zen Upgrades XOMA (NASDAQ:XOMA) to Buy - Defense World
HC Wainwright Issues Positive Outlook for XOMA Earnings - Defense World
XOMA Co. (NASDAQ:XOMAO) Short Interest Update - Defense World
XOMA Co. (NASDAQ:XOMAP) Short Interest Update - Defense World
XOMA’s (XOMA) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
XOMA Royalty purchases mezagitamab royalty rights from BioInvent International for $30M - MSN
XOMA stock holds Buy rating, $104 target from H.C. Wainwright - Investing.com
XOMA stock holds Buy rating, $104 target from H.C. Wainwright By Investing.com - Investing.com South Africa
XOMA Royalty Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) - Benzinga
XOMA Stock: HC Wainwright & Co. Reiterates Buy Rating with $104 - GuruFocus
XOMA Purchases Future Mezagitamab Royalty Interests from BioInve - GuruFocus
XOMA Royalty (XOMA) Acquires Mezagitamab Interests from BioInvent - GuruFocus
XOMA Royalty (XOMA) Acquires Mezagitamab Interests from BioInven - GuruFocus
XOMA Royalty Purchases Mezagitamab Royalty and Milestone - GlobeNewswire
XOMA Royalty Purchases Mezagitamab Royalty and Milestone Rights Held by BioInvent International for up to USD $30 Million - Yahoo Finance
Northern Trust Corp Has $2.40 Million Holdings in XOMA Co. (NASDAQ:XOMA) - Defense World
XOMA (NASDAQ:XOMAO) Stock Price Up 0.1% – Still a Buy? - Defense World
XOMA (NASDAQ:XOMAP) Trading Up 1.5% – Still a Buy? - Defense World
Major Shareholder Sells Massive Chunk of Xoma Stock! - TipRanks
Leerink Partnrs Analysts Boost Earnings Estimates for XOMA - Defense World
FY2026 Earnings Estimate for XOMA Issued By Leerink Partnrs - Defense World
Results: XOMA Royalty Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates - Yahoo Finance
XOMA Royalty First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
XOMA Royalty Reports Strong Q1 2025 Results - TipRanks
XOMA Royalty Corp Q1 2025 Earnings: EPS of $0.24, Revenue Surges to $15.9 Million, Exceeding Estimates - GuruFocus
XOMA (XOMA) Surpasses Q1 Revenue Expectations with Strong Pipeli - GuruFocus
XOMA Royalty (XOMA) Tops Q1 Earnings and Revenue Estimates - Yahoo Finance
XOMA Royalty Corporation Q1 2025 Financial Results - TradingView
XOMA Royalty Corp SEC 10-Q Report - TradingView
XOMA Royalty Reports First Quarter 2025 Financial Results and Highlights Business Achievements - The Manila Times
Wells Fargo & Company MN Grows Stock Holdings in XOMA Co. (NASDAQ:XOMA) - Defense World
Barclays PLC Acquires 1,528 Shares of XOMA Co. (NASDAQ:XOMA) - Defense World
XOMA Royalty to Present at H.C. Wainwright 1st Annual Royalty Company Virtual Conference - GlobeNewswire
XOMA Royalty Corp expected to post a loss of 30 cents a shareEarnings Preview - TradingView
Renaissance Technologies LLC Buys 7,619 Shares of XOMA Co. (NASDAQ:XOMA) - Defense World
JPMorgan Chase & Co. Raises Stake in XOMA Co. (NASDAQ:XOMA) - Defense World
XOMA Co. (NASDAQ:XOMAO) Sees Significant Increase in Short Interest - Defense World
XOMA Co. (NASDAQ:XOMA) Shares Sold by Geode Capital Management LLC - Defense World
Short Interest in XOMA Co. (NASDAQ:XOMAP) Drops By 15.9% - Defense World
Benchmark Begins Coverage on XOMA (NASDAQ:XOMA) - Defense World
Benchmark Initiates Coverage of XOMA Royalty CorporationPreferred Stock (XOMAP) with Buy Recommendation - Nasdaq
Benchmark Initiates Coverage of XOMA Royalty (XOMA) with Buy Recommendation - Nasdaq
XOMA Co. (NASDAQ:XOMAO) Sees Large Decrease in Short Interest - Defense World
Third Harmonic's shutdown, Coherus and Xoma drug sales connectedBizwomen - The Business Journals
Big moves by small biotechs signal potential shift for investorsSan Francisco Business Times - The Business Journals
0.29%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):